Clotrimazole enema - AesRx

Drug Profile

Clotrimazole enema - AesRx

Alternative Names: Aes-210; Correcta

Latest Information Update: 25 Jun 2015

Price : $50

At a glance

  • Originator Childrens Hospital Boston
  • Developer AesRx; Childrens Hospital Boston
  • Class Antifungals; Imidazoles; Small molecules
  • Mechanism of Action 14-alpha demethylase inhibitors; Cell membrane modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Pouchitis
  • New Molecular Entity No

Highest Development Phases

  • No development reported Pouchitis

Most Recent Events

  • 25 Jun 2015 No recent reports of development identified - Phase-II for Pouchitis (In children) in USA (Rectal)
  • 25 Jun 2015 No recent reports of development identified - Phase-II for Pouchitis in USA (Rectal)
  • 09 Jul 2014 AesRx has been acquired by Baxter International
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top